Moderna, the famed vaccine maker is reportedly in late-stage investment talks for a research facility in Britain.
The Financial Times has reported the US biotech giant is looking to collaborate with the NHS in a move which would be a “key element” of the UK’s post-Brexit ambition to become a global life sciences hub.
According to the report the move “would seat the UK in a prime position in the development of new vaccines and therapeutics.”
It is understood Moderna are looking at sites in London, Oxford or Cambridge.
The report comes after Health Secretary Sajid Javid met with CEO of the Boston-based biotech Stephane Bacel last week and said:
“The UK is ideally placed to become a life sciences superpower, and collaboration with world leading companies is crucial to this.”
Conservative Post has contacted Moderna and the Department for Health and Social Care for comment.
Photo licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 2.0 Generic License.
